The HSD17B13 rs72613567 variant is associated with lower levels of albuminuria in patients with biopsy-proven nonalcoholic fatty liver disease.

doi:10.1016/j.numecd.2021.02.018

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

The HSD17B13 rs72613567 variant is associated with lower levels of albuminuria in patients with biopsy-proven nonalcoholic fatty liver disease.

Nutrition, metabolism, and cardiovascular diseases : NMCD - 7 Jun 2021

Sun Dan-Qin, Wang Ting-Yao, Zheng Kenneth I, Zhang Hao-Yang, Wang Xiao-Dong, Targher Giovanni, Byrne Christopher D, Chen Yong-Ping, Yuan Wei-Jie, Jin Yan, Zheng Ming-Hua

Abstract excerpt

BACKGROUND AND AIMS: Several susceptibility gene variants predisposing to nonalcoholic fatty liver disease (NAFLD) have been identified in chronic kidney disease (CKD). Evidence supports that 17-beta hydroxysteroid dehydrogenase 13 (HSD17B13) rs72613567 plays a role in NAFLD development by affecting lipid homeostasis. Since lipid droplets may accumulate in the kidneys and contribute to renal injury, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 17-Hydroxysteroid Dehydrogenases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Albuminuria

Share to Biopsy

Share to Cross-Sectional Studies

Share to Glomerular Filtration Rate

Share to Kidney

Share to Lipocalin-2

Share to Non-alcoholic Fatty Liver Disease

Source

Open in PubMed

Identifiers

PMID: 33853719
DOI: 10.1016/j.numecd.2021.02.018

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The HSD17B13 rs72613567 variant is associated with lower levels of albuminuria in patients with biopsy-proven nonalcoholic fatty liver disease.PMID 33853719Read ↗

Pediatric non-alcoholic fatty liver disease and kidney function: Effect of HSD17B13 variant.Semantic proximity Read ↗

17‐Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Splice variant rs72613567 prevents worst histologic outcomes in patients with nonalcoholic fatty liver diseaseSemantic proximity Read ↗

HSD17B13: A Potential Therapeutic Target for NAFLDSemantic proximity Read ↗

Nonalcoholic Fatty Liver Disease (NAFLD), But not Its Susceptibility Gene Variants, Influences the Decrease of Kidney Function in Overweight/Obese ChildrenSemantic proximity Read ↗

Loss-of-function HSD17B13 variants, non-alcoholic steatohepatitis and adverse liver outcomes: Results from a multi-ethnic Asian cohort.Semantic proximity Read ↗

Genetic variation of HSD17B13 is associated with an increased risk of lean nonalcoholic fatty liver diseaseSemantic proximity Read ↗

A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease.Semantic proximity Read ↗

Is HSD17B13 Genetic Variant a Protector for Liver Dysfunction? Future Perspective as a Potential Therapeutic TargetSemantic proximity Read ↗

Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver disease.Semantic proximity Read ↗

Relationship Between PNPLA3 rs738409 Polymorphism and Decreased Kidney Function in Children With NAFLDSemantic proximity Read ↗

PARVB and HSD17B13 variants are associated with nonalcoholic fatty liver disease in children.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.